Updated clinical guideline for human papillomavirus vaccine: the Korean Society of Gynecologic Oncology guidelines

J Gynecol Oncol. 2021 Nov;32(6):e94. doi: 10.3802/jgo.2021.32.e94.

Abstract

Since the human papillomavirus (HPV) vaccine guidelines were developed by the Korean Society of Gynecologic Oncology (KSGO) in 2011, 2016, and 2019, several recent studies on the efficacy and safety of HPV vaccines in middle-aged women and men have been reported. Furthermore, there has been an ongoing debate regarding the efficacy of the HPV vaccine in women with prior HPV infection or who have undergone conization for cervical intraepithelial neoplasia (CIN). We searched and reviewed studies on the efficacy and safety of the HPV vaccine in middle-aged women and men and the efficacy of the HPV vaccine in patients infected with HPV and those who underwent conization for CIN. The KSGO updated their guidelines based on the results of the studies included in this review.

Keywords: Female; Male; Middle Aged; Papillomavirus Vaccines; Practice Guideline.

Publication types

  • Review

MeSH terms

  • Female
  • Humans
  • Male
  • Middle Aged
  • Papillomaviridae
  • Papillomavirus Infections* / complications
  • Papillomavirus Infections* / prevention & control
  • Papillomavirus Vaccines*
  • Republic of Korea
  • Uterine Cervical Dysplasia* / prevention & control
  • Uterine Cervical Neoplasms* / prevention & control

Substances

  • Papillomavirus Vaccines